Prebiotic effect of sialylated immunoglobulin G on gut microbiota of patients with inflammatory bowel disease by in vitro fermentation

[1]  Zhonghua Liu,et al.  Fermentation characteristics and probiotic activity of a purified fraction of polysaccharides from Fuzhuan brick tea , 2022, Food Science and Human Wellness.

[2]  Xiaoxiong Zeng,et al.  Commensal Relationship of Three Bifidobacterial Species Leads to Increase of Bifidobacterium in Vitro Fermentation of Sialylated Immunoglobulin G by Human Gut Microbiota. , 2020, Journal of agricultural and food chemistry.

[3]  E. Daneshzad,et al.  Effect of probiotic and synbiotic supplementation on inflammatory markers in health and disease status: A systematic review and meta-analysis of clinical trials. , 2020, Clinical nutrition.

[4]  F. Turroni,et al.  Bifidobacterium bifidum: A Key Member of the Early Human Gut Microbiota , 2019, Microorganisms.

[5]  F. Enam,et al.  Prebiotics: tools to manipulate the gut microbiome and metabolome , 2019, Journal of Industrial Microbiology & Biotechnology.

[6]  K. S. Kim,et al.  Microbiota-Derived Lactate Accelerates Intestinal Stem-Cell-Mediated Epithelial Development. , 2018, Cell host & microbe.

[7]  Xiaoxiong Zeng,et al.  Characterization of Bovine Serum Albumin and (-)-Epigallocatechin Gallate/3,4- O-Dicaffeoylquinic Acid/Tannic Acid Layer by Layer Assembled Microcapsule for Protecting Immunoglobulin G in Stomach Digestion and Release in Small Intestinal Tract. , 2018, Journal of agricultural and food chemistry.

[8]  R. P. Ross,et al.  Bifidobacterium breve CCFM683 could ameliorate DSS-induced colitis in mice primarily via conjugated linoleic acid production and gut microbiota modulation , 2018, Journal of Functional Foods.

[9]  Zhaohua Shen,et al.  Relationship between intestinal microbiota and ulcerative colitis: Mechanisms and clinical application of probiotics and fecal microbiota transplantation , 2018, World journal of gastroenterology.

[10]  R. M. Anthony,et al.  Engineered Sialylation of Pathogenic Antibodies In Vivo Attenuates Autoimmune Disease , 2017, Cell.

[11]  Y. Naito,et al.  Gut microbiota in the pathogenesis of inflammatory bowel disease , 2018, Clinical Journal of Gastroenterology.

[12]  S. Ou,et al.  Digestion under saliva, simulated gastric and small intestinal conditions and fermentation in vitro of polysaccharides from the flowers of Camellia sinensis induced by human gut microbiota. , 2017, Food & function.

[13]  T. Urashima,et al.  Bifidobacterium bifidum Extracellular Sialidase Enhances Adhesion to the Mucosal Surface and Supports Carbohydrate Assimilation , 2017, mBio.

[14]  Michael J. Miller,et al.  Human milk oligosaccharide consumption by probiotic and human-associated bifidobacteria and lactobacilli. , 2017, Journal of dairy science.

[15]  Chibuike C. Udenigwe,et al.  Structural features underlying prebiotic activity of conventional and potential prebiotic oligosaccharides in food and health , 2017 .

[16]  G. Barton,et al.  Maternal IgG and IgA Antibodies Dampen Mucosal T Helper Cell Responses in Early Life , 2016, Cell.

[17]  Kazuhiko Yamamoto,et al.  Sialylation converts arthritogenic IgG into inhibitors of collagen-induced arthritis , 2016, Nature Communications.

[18]  G. Núñez,et al.  Gut Microbiota-Induced Immunoglobulin G Controls Systemic Infection by Symbiotic Bacteria and Pathogens. , 2016, Immunity.

[19]  G. Kaplan,et al.  The global burden of IBD: from 2015 to 2025 , 2015, Nature Reviews Gastroenterology &Hepatology.

[20]  M. Litwin,et al.  The effect of dietary fibre preparations from potato starch on the growth and activity of bacterial strains belonging to the phyla Firmicutes, Bacteroidetes, and Actinobacteria , 2015 .

[21]  J. Lünemann,et al.  Sialylation of IgG Fc domain impairs complement-dependent cytotoxicity. , 2015, The Journal of clinical investigation.

[22]  F. Turroni,et al.  Glycan cross-feeding activities between bifidobacteria under in vitro conditions , 2015, Front. Microbiol..

[23]  James Kinross,et al.  The gut microbiota and host health: a new clinical frontier , 2015, Gut.

[24]  T. Kanai,et al.  The gut microbiota and inflammatory bowel disease , 2014, Seminars in Immunopathology.

[25]  M. O'Connell Motherway,et al.  Cross-feeding by Bifidobacterium breve UCC2003 during co-cultivation with Bifidobacterium bifidum PRL2010 in a mucin-based medium , 2014, BMC Microbiology.

[26]  Gillian Dekkers,et al.  IgG Subclasses and Allotypes: From Structure to Effector Functions , 2014, Front. Immunol..

[27]  Y. Rombouts,et al.  Immunoglobulin G (IgG) Fab Glycosylation Analysis Using a New Mass Spectrometric High-throughput Profiling Method Reveals Pregnancy-associated Changes* , 2014, Molecular & Cellular Proteomics.

[28]  M. O'Connell Motherway,et al.  Metabolism of Sialic Acid by Bifidobacterium breve UCC2003 , 2014, Applied and Environmental Microbiology.

[29]  Harry J Flint,et al.  Prebiotic stimulation of human colonic butyrate-producing bacteria and bifidobacteria, in vitro. , 2014, FEMS microbiology ecology.

[30]  P. Bork,et al.  Richness of human gut microbiome correlates with metabolic markers , 2013, Nature.

[31]  Mathieu Almeida,et al.  Dietary intervention impact on gut microbial gene richness , 2013, Nature.

[32]  Robert C. Edgar,et al.  UPARSE: highly accurate OTU sequences from microbial amplicon reads , 2013, Nature Methods.

[33]  J. Paul,et al.  Fluctuations in butyrate-producing bacteria in ulcerative colitis patients of North India. , 2013, World journal of gastroenterology.

[34]  R. Rao,et al.  Protection and Restitution of Gut Barrier by Probiotics: Nutritional and Clinical Implications. , 2013, Current nutrition and food science.

[35]  R. Rastall,et al.  Human milk and related oligosaccharides as prebiotics. , 2013, Current opinion in biotechnology.

[36]  Xin Wang,et al.  The biodiversity and composition of the dominant fecal microbiota in patients with inflammatory bowel disease. , 2013, Diagnostic microbiology and infectious disease.

[37]  K. Honda,et al.  The microbiome in infectious disease and inflammation. , 2012, Annual review of immunology.

[38]  A. Lux,et al.  The role of sialic acid as a modulator of the anti-inflammatory activity of IgG , 2012, Seminars in Immunopathology.

[39]  J. Clemente,et al.  The Impact of the Gut Microbiota on Human Health: An Integrative View , 2012, Cell.

[40]  A. Nusrat,et al.  Gastrointestinal , Hepatobiliary , and Pancreatic Pathology Probiotic Bacteria Induce Maturation of Intestinal Claudin 3 Expression and Barrier Function , 2012 .

[41]  Subrata Ghosh,et al.  Increasing incidence and prevalence of the inflammatory bowel diseases with time, based on systematic review. , 2012, Gastroenterology.

[42]  Armin Ruf,et al.  Unique carbohydrate–carbohydrate interactions are required for high affinity binding between FcγRIII and antibodies lacking core fucose , 2011, Proceedings of the National Academy of Sciences.

[43]  R. Xavier,et al.  Genetics and pathogenesis of inflammatory bowel disease , 2011, Nature.

[44]  T. Klaenhammer,et al.  Regulation of induced colonic inflammation by Lactobacillus acidophilus deficient in lipoteichoic acid , 2011, Proceedings of the National Academy of Sciences.

[45]  Aldert L. Zomer,et al.  Genome analysis of Bifidobacterium bifidum PRL2010 reveals metabolic pathways for host-derived glycan foraging , 2010, Proceedings of the National Academy of Sciences.

[46]  J. Ravetch,et al.  A Novel Role for the IgG Fc Glycan: The Anti-inflammatory Activity of Sialylated IgG Fcs , 2010, Journal of Clinical Immunology.

[47]  P. Bork,et al.  A human gut microbial gene catalogue established by metagenomic sequencing , 2010, Nature.

[48]  M. Claesson,et al.  Antigen‐presenting cells exposed to Lactobacillus acidophilus NCFM, Bifidobacterium bifidum BI‐98, and BI‐504 reduce regulatory T cell activity , 2010, Inflammatory bowel diseases.

[49]  B. Roe,et al.  A core gut microbiome in obese and lean twins , 2008, Nature.

[50]  G. Gibson,et al.  Prebiotic evaluation of a novel galactooligosaccharide mixture produced by the enzymatic activity of Bifidobacterium bifidum NCIMB 41171, in healthy humans: a randomized, double-blind, crossover, placebo-controlled intervention study. , 2008, The American journal of clinical nutrition.

[51]  D. Jonkers,et al.  Review article: the role of butyrate on colonic function , 2007, Alimentary pharmacology & therapeutics.

[52]  M. Langman,et al.  Impaired Detoxication of Hydrogen Sulfide in Ulcerative Colitis? , 2007, Digestive Diseases and Sciences.

[53]  E. Mardis,et al.  An obesity-associated gut microbiome with increased capacity for energy harvest , 2006, Nature.

[54]  J. Ravetch,et al.  Anti-Inflammatory Activity of Immunoglobulin G Resulting from Fc Sialylation , 2006, Science.

[55]  E. Purdom,et al.  Diversity of the Human Intestinal Microbial Flora , 2005, Science.

[56]  L. Morelli,et al.  Beneficial effect of auto-aggregating Lactobacillus crispatus on experimentally induced colitis in mice. , 2005, FEMS immunology and medical microbiology.

[57]  D. James,et al.  Control of Recombinant Monoclonal Antibody Effector Functions by Fc N‐Glycan Remodeling in Vitro , 2005, Biotechnology progress.

[58]  M. Roberfroid,et al.  Dietary modulation of the human colonic microbiota: updating the concept of prebiotics , 2004, Nutrition Research Reviews.

[59]  Kouhei Tsumoto,et al.  Fucose depletion from human IgG1 oligosaccharide enhances binding enthalpy and association rate between IgG1 and FcgammaRIIIa. , 2004, Journal of molecular biology.

[60]  S. Ahrné,et al.  Modulation of the Effect of Dextran Sulfate Sodium-Induced Acute Colitis by the Administration of Different Probiotic Strains of Lactobacillus and Bifidobacterium , 2004, Digestive Diseases and Sciences.

[61]  W. Babidge,et al.  Colonic Sulfide in Pathogenesis and Treatment of Ulcerative Colitis , 1997, Digestive Diseases and Sciences.

[62]  J. Pollard,et al.  Colony-stimulating factor-1-dependent macrophages are responsible for IVIG protection in antibody-induced autoimmune disease. , 2003, Immunity.

[63]  K. Shitara,et al.  The Absence of Fucose but Not the Presence of Galactose or Bisecting N-Acetylglucosamine of Human IgG1 Complex-type Oligosaccharides Shows the Critical Role of Enhancing Antibody-dependent Cellular Cytotoxicity* , 2003, The Journal of Biological Chemistry.

[64]  L. Presta,et al.  Lack of Fucose on Human IgG1 N-Linked Oligosaccharide Improves Binding to Human FcγRIII and Antibody-dependent Cellular Toxicity* , 2002, The Journal of Biological Chemistry.

[65]  R. Farrell,et al.  Microbial factors in inflammatory bowel disease. , 2002, Gastroenterology clinics of North America.

[66]  G R Gibson,et al.  Dietary modulation of the human colonic microbiota: introducing the concept of prebiotics. , 1995, The Journal of nutrition.